SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress

Source :: GlobeNewswire. May 11, 2023
Publication Year :: 2023
Abstract: STAMFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, [...]

Subjects :: United States. Food and Drug Administration -- Political activity
Medical research -- Political aspects
Medicine, Experimental -- Political aspects
Multiple myeloma -- Political aspects
Clinical trials -- Political aspects
Banking, finance and accounting industries
Business

Tools